{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:04:56Z","timestamp":1791284696822,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jns.2016.08.028","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T02:17:29Z","timestamp":1471313849000},"page":"286-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Bradykinesia in early and advanced Parkinson's disease"],"prefix":"10.1016","volume":"369","author":[{"given":"Matteo","family":"Bologna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Leodori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Stirpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Paparella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Colella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Belvisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Fabbrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2016.08.028_bb0005","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/124.11.2131","article-title":"Pathophysiology of bradykinesia in Parkinson\u2019s disease","volume":"124","author":"Berardelli","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.08.028_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/mds.21198","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan","volume":"22","author":"Goetz","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10072-012-1112-z","article-title":"Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale","volume":"34","author":"Antonini","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2016.08.028_bb0020","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/115.5.1481","article-title":"Sequential arm movements in patients with Parkinson\u2019s disease, Huntington's disease and dystonia","volume":"115","author":"Agostino","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.08.028_bb0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mds.870090305","article-title":"Analysis of repetitive and non repetitive sequential arm movements in patients with Parkinson\u2019s disease","volume":"9","author":"Agostino","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0030","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/mds.22480","article-title":"Impairments of speed and amplitude of movement in Parkinson\u2019s disease: a pilot study","volume":"24","author":"Espay","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0035","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/mds.23893","article-title":"Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson\u2019s disease","volume":"26","author":"Espay","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0040","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/brain\/aws038","article-title":"Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson\u2019s disease","volume":"135","author":"Ling","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.08.028_bb0045","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/mds.10313","article-title":"Impairment of individual finger movements in Parkinson\u2019s disease","volume":"18","author":"Agostino","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.clinph.2013.09.004","article-title":"Modulation of corticomotor excitability after maximal or sustainable-rate repetitive finger movement is impaired in Parkinson's disease and is reversed by levodopa","volume":"125","author":"Teo","year":"2014","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2016.08.028_bb0055","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/mds.20998","article-title":"The sequence effect and gait festination in Parkinson disease: contributors to freezing of gait?","volume":"9","author":"Iansek","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0060","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/mds.22077","article-title":"Quantitative measures of fine motor, limb, and postural bradykinesia in very early stage, untreated Parkinson\u2019s disease","volume":"23","author":"Koop","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14802\/jmd.11006","article-title":"The sequence effect in de novo Parkinson\u2019s disease","volume":"4","author":"Kang","year":"2011","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0070","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.parkreldis.2014.09.027","article-title":"Neural correlates of progressive reduction of bradykinesia in de novo Parkinson\u2019s disease","volume":"20","author":"Lee","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archneur.64.1.20","article-title":"Circuits and circuit disorders of the basal ganglia","volume":"64","author":"DeLong","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2016.08.028_bb0080","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1016\/S1353-8020(09)70822-3","article-title":"Update on models of basal ganglia function and dysfunction","volume":"15","author":"DeLong","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0085","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/ana.21481","article-title":"The basal ganglia in Parkinson\u2019s disease: current concepts and unexplained observations","volume":"64","author":"Obeso","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2016.08.028_bb0090","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/mds.23695","article-title":"Milestones in research on the pathophysiology of Parkinson\u2019s disease","volume":"26","author":"Wichmann","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0095","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/brain\/awu381","article-title":"Dopaminergic modulation of motor network dynamics in Parkinson\u2019s disease","volume":"138","author":"Michely","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.08.028_bb0100","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/mds.23251","article-title":"Characteristics of the sequence effect in Parkinson\u2019s disease","volume":"25","author":"Kang","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0404.2012.01652.x","article-title":"Cerebral blood flow and freezing of gait in Parkinson\u2019s disease","volume":"126","author":"Imamura","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2016.08.028_bb0110","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/WNF.0b013e318255838b","article-title":"Selegiline: a reappraisal of its role in Parkinson disease","volume":"35","author":"Fabbrini","year":"2012","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jns.2016.08.028_bb0115","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/mds.23714","article-title":"Milestones in Parkinson\u2019s disease therapeutics","volume":"26","author":"Rascol","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/WCO.0b013e3283542fc2","article-title":"Therapies in Parkinson\u2019s disease","volume":"25","author":"Jankovic","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2016.08.028_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2012.03866.x","article-title":"Summary of the recommendations of the EFNS\/MDS-ES review on therapeutic management of Parkinson\u2019s disease","volume":"20","author":"Ferreira","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2016.08.028_bb0130","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mds.26048","article-title":"Norepinephrine deficiency in Parkinson\u2019s disease: the case for noradrenergic enhancement","volume":"29","author":"Espay","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/ene.12022","article-title":"EFNS\/MDS-ES\/ENS [corrected] recommendations for the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Berardelli","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2016.08.028_bb0140","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0145","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.parkreldis.2015.06.015","article-title":"Effects of cerebellar continuous theta burst stimulation on resting tremor in Parkinson\u2019s disease","volume":"21","author":"Bologna","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2016.08.028_bb0150","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nrn2478","article-title":"Functional role of the supplementary and pre-supplementary motor areas","volume":"9","author":"Nachev","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jns.2016.08.028_bb0155","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/brain\/awv319","article-title":"Neural correlates underlying micrographia in Parkinson\u2019s disease","volume":"139","author":"Wu","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.08.028_bb0160","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.parkreldis.2014.02.022","article-title":"Clinician versus machine: reliability and responsiveness of motor endpoints in Parkinson\u2019s disease","volume":"20","author":"Heldman","year":"2014","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16305196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16305196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T09:04:54Z","timestamp":1531472694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16305196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":32,"alternative-id":["S0022510X16305196"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.08.028","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bradykinesia in early and advanced Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}